About this trial
This study is a longitudinal observational study that will investigate the feasibility of using mobile devices for the assessment of HRQoL and physical activity in adult cancer patients undergoing treatment. Patients will complete a set of patient reported outcome measures (PROMs), and wear a smartwatch (min. 10 hours per day for one week), at baseline, and at weeks 4, 8 and 12 after treatment start.
Eligibility criteria
Qualifiers
Diagnosis of cancer
Age≥18
Starting a first or new anticancer treatment within one month following enrolment
Literacy in the target language
Disqualifiers
Exclusively receiving palliative care
Start of cancer-related treatment < 1 week from time of screening
Any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; those conditions should be assessed and discussed with the patient before enrolment in this study.
Trial design
Treatments tested in this trial
- Not listed